Answers are grounded in this paper and cite their sources.
This research demonstrates potential polymyxins reducing nephrotoxicity, indicating alternatives to combat antimicrobial resistance.
Despite their nephrotoxicity, polymyxins remain in clinical use as last-resort antibiotics, underscoring the urgent need for alternatives amid rising antimicrobial resistance.
No takes yet. Share an insight, caveat, or question.
Kowalczyk et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: